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ABSTRACT
Formaldehyde is not only a widely used chemical with well-known carcinogenicity but is also a normal metabolite of living
cells. It thus poses unique challenges for understanding risks associated with exposure. N2-hydroxymethyl-dG (N2-HOMe-
dG) is the main formaldehyde-induced DNA mono-adduct, which together with DNA-protein crosslinks (DPCs) and toxicity-
induced cell proliferation, play important roles in a mutagenic mode of action for cancer. In this study, N2-HOMe-dG was
shown to be an excellent biomarker for direct adduction of formaldehyde to DNA and the hydrolysis of DPCs. The use of
inhaled [13CD2]-formaldehyde exposures of rats and primates coupled with ultrasensitive nano ultra performance liquid
chromatography-tandem mass spectrometry permitted accurate determinations of endogenous and exogenous
formaldehyde DNA damage. The results show that inhaled formaldehyde only reached rat and monkey noses, but not
tissues distant to the site of initial contact. The amounts of exogenous adducts were remarkably lower than those of
endogenous adducts in exposed nasal epithelium. Moreover, exogenous adducts accumulated in rat nasal epithelium over
the 28-days exposure to reach steady-state concentrations, followed by elimination with a half-life (t1/2) of 7.1 days.
Additionally, we examined artifact formation during DNA preparation to ensure the accuracy of nonlabeled N2-HOMe-dG
measurements. These novel findings provide critical new data for understanding major issues identified by the National
Research Council Review of the 2010 Environmental Protection Agency’s Draft Integrated Risk Information System
Formaldehyde Risk Assessment. They support a data-driven need for reflection on whether risks have been overestimated
for inhaled formaldehyde, whereas underappreciating endogenous formaldehyde as the primary source of exposure that
results in bone marrow toxicity and leukemia in susceptible humans and rodents deficient in DNA repair.
Key words: formaldehyde; DNA-protein crosslinks; DNA monoadducts; artifacts; endogenous and exogenous; distribution;
accumulation; steady state; half-life; nano liquid chromatography-tandem mass spectrometry
Formaldehyde was first shown to be a carcinogen in 1980, caus-
ing squamous cell carcinomas in nasal passages of exposed rats
(Swenberg et al., 1980). It was classified as a known human and
animal carcinogen in 2006 (International Agency for Research
on Cancer, 2006, 2012). Although widespread human exposure
has raised longstanding public health concerns, formaldehyde
is also an essential metabolic intermediate in all living cells.
Formaldehyde is highly genotoxic due to its ability to covalently
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bind and induce DNA monoadducts (McGhee and von Hippel,
1977), DNA-DNA crosslinks (Lu et al., 2010a), DNA-protein cross-
links (DPCs) (Casanova-Schmitz and Heck, 1983; Magana-
Schwencke and Ekert, 1978; Solomon and Varshavsky, 1985),
and DNA-glutathione crosslinks (Lu et al., 2009). The carcino-
genic mode of action is based on the synergism among the for-
mation of DNA mono-adducts, DPCs, and increased cell
proliferation that lead to mutations (International Agency for
Research on Cancer, 2006). Epidemiologic associations have
been reported between formaldehyde exposure and the induc-
tion of leukemia (Beane Freeman et al., 2009). However, whether
or not inhaled formaldehyde exposure causes leukemia
remains debatable. Previous experimental results have not sup-
ported the induction of leukemia (Lu et al., 2010a), and epide-
miological reports have been inconsistent across different
studies (Beane Freeman et al., 2009; Coggon et al., 2014). K.J.
Patel’s laboratory has recently reported that mice deficient in
both acetaldehyde catabolism (ALDH2/) and the Fanconi ane-
mia (FA) DNA repair pathway (FANCD2/), spontaneously
develop severe bone marrow toxicity and acute leukemia
(Garaycoechea et al., 2012; Langevin et al., 2011). Moreover, they
have shown endogenous formaldehyde to be more abundant
and more genotoxic than acetaldehyde (Rosado et al., 2011),
demonstrating that endogenous aldehyde concentrations are
sufficient to cause DNA damage and induce leukemia in FA
mice (Garaycoechea et al., 2012; Langevin et al., 2011).
The U.S. EPA released a draft Integrated Risk Information
System (IRIS) risk assessment in June 2010. The National
Research Council (NRC) was asked to conduct an independent
scientific review of the draft IRIS assessment, which raised 5
issues related to toxicokinetics and modes of action of
formaldehyde (Committee to Review EPA’s Draft IRIS
Assessment of Formaldehyde & National Research Council,
2011). First, the normal presence of formaldehyde in all tissues,
cells, and bodily fluids complicates any formaldehyde risk
assessment. Thus, an improved understanding of when exoge-
nous inhaled formaldehyde exposure alters normal endogenous
or total formaldehyde tissue concentrations was identified as a
critical need. Second, inhaled formaldehyde is found predomi-
nantly in the respiratory epithelium. The draft IRIS assessment
presented divergent opinions regarding the systemic delivery of
formaldehyde that need greater resolution. Third, the commit-
tee agreed with EPA that formaldehyde may act through a
mutagenic mode of action. However, cytotoxicity and compen-
satory cell proliferation also play critical roles in formaldehyde-
induced nasal tumors. The NRC committee recommended that
EPA provide alternative calculations that factor in nonlinearities
associated with the cytotoxicity-cell proliferation mode of
action. Fourth, the NRC recommended that biologically based
dose-response models be used. Fifth, the NRC recommended
that EPA carefully consider the implications of recent analytical
techniques that achieve superior sensitivity and can be highly
informative in accurately distinguishing between and quantify-
ing separately exogenous and endogenous formaldehyde-
induced DNA mono-adducts and DPCs in tissues (Lu et al.,
2010a).
The research presented here is directly responsive to and
provides critical information for understanding the major issues
identified by the NRC. Of particular importance is the demon-
stration that exogenous DNA adducts from inhaled formalde-
hyde do not reach quasi-steady-state concentrations until
approximately 28-days of exposure to 2 ppm [13CD2]-formalde-
hyde (6 h/day, 7 days/week). Thus, for the first time, it is possi-
ble to make accurate determinations of both exogenous and
endogenous formaldehyde contributions to the total
DNA adduct burden. With the support of ultrasensitive nano
ultra performance liquid chromatography-tandem mass spec-
trometry (nano-UPLC-MS-MS), we demonstrate the accumula-
tion of exogenous adducts, as well as the approximate time
to steady state, and estimation of the t1/2 for the repair/loss
of DNA damage in vivo. We also provide data regarding the
tissue-specific distribution patterns of the exogenous and
endogenous DNA adducts, and show N2-HOMe-dG to be the
dominant degradation product of several DPCs, demonstrat-
ing that it is an excellent biomarker for both DPCs and direct
adduction of formaldehyde to DNA. Finally, we carefully
examined artifact formation during DNA isolation and diges-
tion to ensure the accuracy of nonlabeled N2-HOMe-dG meas-
urements. These studies provide the amounts of endogenous
DNA adducts that arise from both direct adduction and
hydrolysis of DPCs for several tissues in control and exposed
animals. Our data constitute critical information for under-
standing the roles of both endogenous and exogenous form-




20-Deoxyguanosine, reduced L-glutathione, Tris-EDTA (TE buf-
fer), sodium phosphate monobasic (BioXtra), sodium phosphate
dibasic (BioXtra), Trizma hydrochloride (BioXtra, BioUltra,
BioPerformance), Trizma base (BioXtra), piperazine-N,N0-bis(2-
ethanesulfonic acid) (PIPES), magnesium chloride solution,
ammonium acetate, acetic acid, formic acid, sodium cyanoboro-
hydride (NaCNBH3), N
2-Me-dG, 2,2,6,6-tetramethylpiperidine-1-
oxyl (TEMPO), leucine aminopeptidase M, carboxypeptidase Y,
alkaline phosphatase, phosphodiesterase, DNase I, and DNA
single stranded oligo 50-T7GT7-30 (15-mer) were all purchased
from Sigma (St Louis, Missouri). N-Terminal acetylated 12-mer
human O6-alkylguanine DNA methyltransferase (Acetyl-
GNPVPILIPCHR, AGT) peptide was synthesized by Genscript
Corporation (Piscataway, New Jersey). Methanol, acetonitrile,
high-performance liquid chromatography (HPLC) grade water,
and optima LC-MS grade water were all purchased from
Thermo Fisher Scientific (Pittsburgh, Pennsylvania). High-purity
LC-MS grade water and acetonitrile were purchased from
Burdick and Jackson Honeywell (Muskegon, Michigan). A 20%
solution of formaldehyde in H2O was procured from Tousimis
(Rockville, Maryland). [13C10
15N5]-dG and a 20% solution of
[13CD2]-formaldehyde in D2O were obtained from Cambridge
Isotope Laboratories, Inc (Cambridge, Massachusetts).
Chemical Hazards
Formaldehyde is a highly reactive compound and a known car-
cinogen and should be handled within a fume hood using
appropriate personal protection equipment (PPE).
Synthesis of dG-Me-GSH Crosslink
The synthesis of dG-Me-GSH was carried out according to a pre-
vious report (Lu et al., 2010b). Briefly, glutathione (85 mM) was
incubated with formaldehyde (100 mM) in 1.75 ml sodium phos-
phate buffer (100 mM, pH 7.2) at 37C for 4 h. dG was then added
to a final concentration of 16 mM. The reaction mixture was fur-
ther incubated at 37C for 6 h. The purification of dG-Me-GSH
was performed on an Agilent 1200 series UV HPLC system
(Agilent Technologies, Santa Clara, California). The analyte was
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separated on a C18 reverse phase column (Waters Atlantis T3,
3 mm, 150  4.6 mm, Waters Corporation, Milford,
Massachusetts). The mobile phases were 0.05% acetic acid in
water (A) and pure acetonitrile (B). The column temperature
was kept at 15C. The flow rate was 0.45 ml/min with a starting
condition of 2% B, which was held for 3 min, followed by a linear
gradient up to 15% B at 20 min, and held for 8 min, followed by
7 min at 80% B, then re-equilibrated to the starting conditions
for 10 min. The UV detector was set at 254 nm and dG-Me-GSH
eluted at the retention time (RT) of 24.5 min. The fractions
containing dG-Me-GSH were combined, followed by concentra-
tion using a speed vac.
Synthesis of dG-Me-Cys Crosslink
dG-Me-Cys was synthesized by digestion of dG-Me-GSH using
leucine aminopeptidase M and carboxypeptidase Y. Initially,
dG-Me-GSH was prepared and purified using the same methods
as described earlier. dG-Me-GSH was digested in 1.2 ml sodium
phosphate buffer (40 mM, pH 6.0) in the presence of 33 mg/ml
carboxypeptidase Y, 133 mg/ml leucine aminopeptidase M,
10 mM MgCl2, and 10 mM CaCl2. The mixture was incubated at
room temperature for 16 h and transferred to a centrifugal filter.
Enzymes were removed by centrifugation at 11 000 g for
30 min, and the resultant filtrate was separated by the same
HPLC method as described earlier with a different elution
gradient. The flow was initiated with a starting condition of 2%
B, which was held for 3 min, followed by a linear gradient up to
4.1% B at 42 min, followed by 13 min at 90% B, then re-
equilibrated to the starting conditions for 10 min. dG-Me-Cys
eluted at RT of 38.5 min and the fractions containing dG-Me-Cys
were collected and concentrated in a speed vac.
Synthesis of dG-Me-AGT Crosslink
12-Mer AGT peptide (0.8 mM) was incubated with formaldehyde
(20 mM) in 98 ml sodium phosphate buffer (10 mM, pH 7.2) at
37C for 3 h. Then, 2 ml dG was added to a final concentration of
2 mM, followed by additional incubation at 37C for 7 h. dG-Me-
AGT was purified by the same HPLC method for dG-Me-GSH
crosslink with a different elution gradient. The flow was initi-
ated with a starting condition of 6% B, which was held for
18 min, followed by a linear gradient up to 20% B at 30 min, and
kept for 18 min, then re-equilibrated to the starting conditions
for 12 min. dG-Me-AGT eluted at 44.0 min and the HPLC frac-
tions containing dG-Me-AGT were collected and concentrated
in a speed vac.
Degradation of Crosslinks
To study the kinetics of crosslink degradation, crosslinks in
sodium phosphate buffer (20 mM, pH 7.2) were incubated at
37C. A 25 ml aliquot was removed to determine the concentra-
tion of dG, N2-HOMe-dG, and crosslinks at different time points.
For those samples that were not readily analyzed, they
were acidified with 1.5 ml of 3% acetic acid solution to stop the
degradation of crosslinks and then kept at 4C until analysis.
The analysis of the reaction mixture at different time
points was performed on an Agilent 1200 series UV HPLC
system as described earlier. Isocratic elution with 6% solvent
B at flow rate of 0.45 ml/min was used for dG-Me-Cys and dG-
Me-GSH degradation studies. For dG-Me-AGT degradation anal-
ysis, the flow rate was 0.45 ml/min with a starting condition of
8% B, which was held for 14 min, followed by a linear gradient
up to 30% B at 20 min, and kept for 10 min, then re-equilibrated
to the starting conditions for 10 min. UV detector was set at
254 nm, because dG, N2-HOMe-dG, dG-Me-Cys, dG-Me-GSH, and
dG-Me-AGT shared similar UV absorption at 254 nm
(Supplementary Fig. SI-1). The concentrations of dG, N2-HOMe-
dG, and crosslinks were calculated according to a dG standard
calibration curve ranging from 0.02 to 0.8 mM (Supplementary
Fig. SI-2).
Structural Identification of Synthesized Crosslinks
The synthesized crosslinks were characterized using an Agilent
1200 series diode array detector (DAD) HPLC system coupled
with Agilent quadrupole-time-of-flight (QTOF)-MS (Agilent
Technologies, Santa Clara, California). HPLC separation was car-
ried out on a C18 reverse phase column (Waters Atlantis T3,
3 mm, 150 2.1 mm) with a flow rate at 0.2 ml/min and mobile
phase A (0.05% acetic acid in water) and B (acetonitrile). For the
separation of dG, N2-HOMe-dG, dG-Me-Cys, and dG-Me-GSH,
the flow was initiated with a starting condition of 2% B, which
was held for 5 min, followed by a linear gradient up to 10% B at
10 min, and kept for 8 min, then re-equilibrated to the starting
conditions for 10 min. dG, N2-HOMe-dG, dG-Me-Cys, and dG-Me-
GSH were eluted with retention times of 12.5, 13.5, 12.3, and
14.3 min, respectively. For the separation of dG-Me-AGT, the
flow was initiated with a starting condition of 2% B, which was
held for 3 min, followed by a linear gradient up to 30% B at
20 min, and kept for 5 min, then re-equilibrated to the starting
conditions for 10 min. dG-Me-AGT was eluted with RT of
20.2 min. The DAD detector was set at 254 nm and the UV lamp
wavelength ranged from 190 to 300 nm. The electrospray ion
source in positive mode with the following conditions were
used: gas temperature, 200C; drying gas flow, 12 l/min; nebu-
lizer, 35 psi; Vcap, 4000 V; fragmentor, 175 V; skimmer, 67 V.
Electrospray ionization (ESI)-MS-MS spectrum of dG-Me-Cys
and dG-Me-GSH was obtained by in source fragmentation,
whereas collision energy was set at 17 V for the fragmentation
of dG-Me-AGT.
Animal Exposures
Test atmospheres of formaldehyde were generated by the ther-
mal depolymerization of [13CD2]-paraformaldehyde (CAS No.
30525-89-4) obtained from Cambridge Isotopes Laboratories,
Inc. Confirmation of the [13CD2]-paraformaldehyde purity and
identity was accomplished using gas chromatography-mass
spectrometry. The test atmospheres of [13CD2]-formaldehyde
were generated from an 80 l Tedlar bag using a peristaltic pump
to deliver vaporized [13CD2]-formaldehyde into the nose-only
chamber supply airflow. The concentration of the exposure
chamber was monitored by collection of Waters XpoSure
Aldehyde Sampler cartridges every 5 min continuously through-
out the exposure. Cartridges were extracted with acetonitrile
and extracts were analyzed by HPLC.
Animal use in this study was approved by the Institutional
Animal Use and Care Committee of The Lovelace Respiratory
Research Institute and was conducted in accordance with the
National Institutes of Health guidelines for the care and use of
laboratory animals. Animals were housed in fully accredited
American Association for Accreditation of Laboratory Animal
Care facilities. Male F344 rats were exposed to 2 ppm [13CD2]-
formaldehyde atmospheres for 7, 14, 21, or 28 consecutive days
(6 h/day) with postexposure at 6, 24, 72, and 168 h using a single
nose-only unit (Lab Products, Seaford, Delaware). Control rats
were exposed to filtered air (6 h/day, 28 days) using nose-only
exposure chambers. Monkeys (cynomolgus macaques) were
whole body exposed to 6 ppm [13CD2]-formaldehyde on 2 con-
secutive days (6 h/day). The air supply was maintained at
approximately 23 l/min, which was controlled with a mass flow
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controller. Control monkeys were whole body exposed to fil-
tered air (6 h/day, 2 days).
Animals were anesthetized with Nembutal (50–60 mg/kg) IP
within 2 h of the end of exposure; 3–5 ml of blood was collected
by cardiac puncture for lymphocyte isolation. Nasal respiratory
epithelium from the right and left sides of the nose and from
the septum were collected, as were entire tissues of white blood
cells, spleen, thymus, tracheal bronchial lymph nodes (TBLN),
mediastinal lymph nodes, trachea, lung, kidney, liver, and
brain. Bone marrow was collected from both femurs by saline
extrusion with a large bore needle. For monkeys, bone marrow
was collected by both saline extrusion and direct scraping.
Tissue samples were collected and immediately frozen on dry
ice followed by storage at 80C. The sacrifice and tissue collec-
tion of air control animals were the same as the exposed
animals.
DNA Isolation, Reduction, and Digestion
DNA was isolated from the tissues using a NucleoBond DNA
isolation kit (Macherey-Nagel, Bethlehem, Pennsylvania), as
instructed by the manufacturer with small modifications. The
resultant DNA was quantified and stored at 80C for further
analysis. Two ml of DNA was diluted in 998 ml of 1X TE buffer and
its amount was quantitated using a Thermo Spectronic BioMate
5 UV-visible spectrophotometer. DNA amounts from different
tissues ranged from 1.1 to 1396.9 mg. To reduce endogenous and
exogenous N2-HOMe-dG to N2-Me-dG, DNA was thawed and
incubated with NaCNBH3 (50 mM) and sodium phosphate buffer
(100 mM, pH 7.2) for 6 h at 37C. Following reduction, DNA was
frozen at 80C until digested. Reduced DNA was thawed, and
200 ml of sodium phosphate/MgCl2 buffer (50/20 mM final con-
centration, pH 7.2) along with 20 fMol (for samples measured on
Thermo Quantum) or 2 fMol (for samples measured on AB
SCIEX) of the internal standard, [13C10
15N5]-N
2-Me-dG, was
added. DNA was digested with DNAse I (200 units), alkaline
phosphatase (5 units), and phosphodiesterase (0.005 units) for
1 h at 37C. Following digestion, hydrolyzed DNA was filtered
with a Pall NanoSep 3 kDa filter (Port Washington, New York) at
8000 rpm for 50 min.
HPLC Purification and Fractionation
Hydrolyzed DNA was injected onto an Agilent 1200 HPLC frac-
tion collection system equipped with a DAD (Agilent
Technologies, Santa Clara, California). Analytes were separated
by reversed-phase liquid chromatography using an Atlantis C18
T3 (150 4.6 mm, 3 mm) column. The column temperature was
kept at 30C. The mobile phases were water with 0.1% acetic
acid (A) and acetonitrile with 0.1% acetic acid (B). The flow rate
was 1.0 ml/min with a starting condition of 2% B, which was
held for 5 min, followed by a linear gradient of 4% B at 20 min,
10% B at 30 min, followed by 6 min at 80% B, then re-equilibrated
to the starting conditions for 20 min. dG and N2-Me-dG eluted
with retention times of 13.1 and 25.5 min, respectively. The
amount of dG in the samples was quantitated by the UV peak
area (k¼ 254 nm) at the corresponding RT using a calibration
curve ranging from 0.02 to 100 nMol dG on column.
Liquid Chromatography-Tandem Mass Spectrometry
LC-MS-MS analyses of N2-HOMe-dG were performed on 2 instru-
ments. First, a TSQ Quantum Ultra triple-stage quadrupole
mass spectrometer (Thermo Scientific, San Jose, California) was
operated in selected reaction monitoring (SRM) mode to detect
and quantify N2-Me-dG. The mass spectrometer was interfaced
with a nano-acquity UPLC system from Waters Corporation
(Milford, Massachusetts). A 20 0.18 mm Symmetry C18 trap col-
umn (5 mm particle size) and a 100 0.1 mm HSS T3 analytical
column (1.8 mm particle size) from Waters were used. The trap
column was kept at room temperature, and the analytical col-
umn temperature was kept at 35C during each run. Mobile
phases were comprised of water with 0.1% acetic acid (A) or ace-
tonitrile with 0.1% acetic acid (B). Analytes were first retained
on a trap column with a flow rate of 5 ml/min of 2% mobile phase
B, followed by transfer to the analytical column with an initial
starting condition of 2% B at 0.6 ml/ min for 5 min followed by a
linear gradient to 30% B over 12.5 min and to 80% B over 1.5 min.
The flow was then held at 80% B for 1 min followed by re-equili-
bration for an additional 5 min. The analytes were introduced to
the mass spectrometer using positive-mode electrospray ion-
ization with a source voltage of 2300 V and no additional gases.
The ion transfer tube was held at 300C and skimmer offset set
to zero. Scan speed was set at 75 ms, scan width at 0.1 mass to
charge ratio (m/z), and a peak width at 0.7 m/z for Q1 and Q3.
Collision energy was set at 17 eV with Argon as the collision gas
set at 1.5 arbitrary units. N2-HOMe-dG was quantified as N2-Me-
dG after reduction using the transition of m/z 282.2 to m/z 166.1,
and [13CD2]-N
2-HOMe-dG was quantified as [13CD2]-N
2-Me-dG
with the transition of m/z 285.2 to m/z 169.1. Two additional
transitions, including m/z 284.2 to m/z 168.1 and m/z 283.2 to
m/z 167.1, were also monitored in case hydrogen-deuterium
(H-D) exchange occurred. Similarly, the transition of m/z 297.2
to m/z 176.1 was chosen for the internal standard, [13C10
15N5]-
N2-Me-dG. The calibration curves were obtained using the inte-
grated peak area and amount of injected analytical standard
and internal standard. The injection volume was 6 ml.
The most sensitive nano-LC-MS-MS instrument was an AB
SCIEX Triple Quad 6500 mass spectrometer (Foster City,
California) operated in SRM mode to detect and quantify N2-Me-
dG. The mass spectrometer was interfaced with an Eksigent
nanoLC Ultra 2D system (Dublin, California). A 150 0.075 mm
Eksigent ChromXP 3C18-CL-120 analytical column (3 mm particle
size) was used. The column was kept at room temperature dur-
ing each run. Mobile phases were comprised of water with 0.1%
formic acid (A) or acetonitrile with 0.1% formic acid (B). Analytes
were injected into the analytical column with an initial starting
condition of 5% B at 0.3 ml/ min for 10 min followed by a linear
gradient to 35% B over 12 min and to 60% B over 1 min. The flow
was then held at 60% B for 6 min followed by re-equilibration for
an additional 10 min. The analytes were introduced to the mass
spectrometer using positive-mode nanospray ionization with a
source voltage of 2400 V, curtain gas of 20 psi, ion source gas of
10 psi, and collision gas setting of 10 arbitrary units. The inter-
face heater temperature was held at 120C. Declustering poten-
tial was set to 25 V, entrance potential was 10 V, collision energy
was 15 eV, and collision cell exit potential was 12 V. The transi-
tions were the same as those used on Thermo TSQ Quantum.
The calibration curves were obtained using the integrated peak
area and amount of injected analytical standard and internal
standard. The injection volume was 1 ml.
Statistical Analysis and Pharmacokinetic Modeling
In vitro hydrolytic degradation of DPCs. For the in vitro hydrolysis
of DPCs, half-life values were calculated using GraphPad
Prism 5.0 (GraphPad Software, San Diego, California) based on a
1 or 2 phase exponential decay model. Data represent
mean 6 standard deviation (SD). Degradation data obtained
from both dG-Me-Cys and dG-Me-GSH were best fit with a single
phase model. Degradation data of dG-Me-AGT were best fit with
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a 2 phase exponential decay model. Samples were measured in
triplicate unless otherwise indicated.
Endogenous N2-HOMe-dG adducts. The statistical significance of
adduct concentration differences were assessed using statistical
tests appropriate to the different experimental designs.
Two-sided unpaired student’s t-tests were used to compare tis-
sue-specific endogenous adduct concentrations in exposed and
air control animals. The 2-sided Dunnett’s test (Dunnett, 1964)
for comparing multiple treatment groups with a common con-
trol group was utilized in assessing differences by treatment
duration in relation to the single air control group employed in
the 28-day exposure study. Concentration differences were con-
sidered to be statistically significant if P< .05 for all statistical
tests.
Estimated half-life (t1/2) and time for exogenous [
13CD2]-N
2-HOMe-dG
adducts to reach a steady-state concentration. Samples were meas-
ured in triplicate unless otherwise indicated; tabulated data rep-
resent mean 6 SD. Modeling of the exogenous adduct data from
28-days study data required a single exponential decay formula-
tion modified to account for the 28 consecutive daily 6-h
exposure periods. This pharmacokinetic model consists of a
single linear compartment with constant, but intermittent, forc-
ing. The model has 2 parameters, A, the asymptotic adduct
concentration with continuous forcing, and T, the mean adduct
lifetime. The contribution to adduct burden from the ith expo-
sure period (i¼ 1, 28) for time t (expressed in days), with
0 t< (i 1)þ 0.25, is given by
A  ð1 expððt ði 1ÞÞ=TÞÞ;
whereas for t (i 1)þ 0.25, the contribution from the ith expo-
sure period is given by:
A  ð1 expð0:25=TÞÞ  expððt ði 1Þ  0:25Þ=TÞÞ:
The total adduct concentration at time t is obtained by sum-
ming the individual contributions from prior and, when appro-
priate, concurrent 6-h exposure periods.
A maximum likelihood estimate of the adduct half-life was
obtained by using the Microsoft Excel 2007 Solver nonlinear
optimization routine and inverse variance weighting of squared
residuals. A likelihood ratio test-based confidence interval (90%)
for the half-life estimate was also generated.
RESULTS
Characterization and In Vitro Degradation of Formaldehyde-Induced
DPCs
Based on previous work in our lab (Lu et al., 2009, 2010b), dG-Me-
GSH and dG-Me-AGT are formed in vitro and contain specific
dG-Me-Cysteine linkages (Fig. 1A). These DPCs were synthesized
by reaction of formaldehyde with GSH or AGT in solution prior
to dG addition. dG-Me-Cys was obtained by digestion of dG-Me-
GSH with aminopeptidase M and carboxypeptidase Y. These
crosslinks showed similar UV spectra to that of dG in wave-
length ranges from 240 to 300 nm (Supplementary Fig. SI-1). The
chemical structures of these crosslinks were characterized
using ESI-QTOF-MS-MS. Two major product ions were observed
from MS-MS spectra of the protonated precursor ion of dG-
Me-Cys, resulting from the loss of the deoxyribosyl group followed
by the additional loss of cysteine (Supplementary Fig. SI-3A).
The MS-MS spectrum of dG-Me-GSH is consistent with results
from our previous study (Lu et al., 2009) showing 2 additional frag-
ment ions caused by the cleavage of the dG-Me and Me-GSH
bonds (Supplementary Fig. SI-3B). As shown in Supplementary
Fig. SI-3C, 2 major product ions having (þ2) charges were gener-
ated from the doubly charged precursor ion of dG-Me-AGT via loss
of the deoxyribosyl group and dG. The accurate masses for parent
crosslinks and their major fragment ions by ESI-QTOF-MS-MS are
summarized in Supplementary Table SI-1, with mass error
<1.69 ppm.
The linkage N2-dG-Me-Cys is chemically labile due to the
active methylene group. Under physiological pH and tempera-
ture, the estimated half-life for dG-Me-Cys and dG-Me-GSH was
11.6 min (R2¼ 0.9823) and 79.6 min (R2¼ 0.9964), respectively
(Fig. 1B and C). The degradation kinetics of dG-Me-AGT con-
sisted of a rapid initial fall with half-life of 7.4 min followed by a
much slower decay phase characterized by a half-life of
90.2 min (PercentFast¼ 36.5%, R2¼ 0.9987) (Fig. 1D). During the
hydrolysis of DPCs, dG could be directly formed if cleavage
occurs between dG and methylene (N2-dG-Me bond). However,
dG was not detected in the first 3, 10, or 20 min incubations
for dG-Me-Cys, dG-Me-AGT, and dG-Me-GSH, respectively
(Fig. 1B–D). On the other hand, N2-HOMe-dG was readily
formed and increased rapidly after initiating incubation of all
crosslinks, suggesting cleavage of the Me-Cys bond, but not
N2-dG-Me bond. dG was only detected after long periods of incu-
bation, because N2-HOMe-dG is also unstable and degrades to
dG. Thus, the mechanism of DPC hydrolysis involves break-
down to N2-HOMe-dG, followed by further degradation to dG
(Fig. 1A). These results suggest that DPCs may be important
sources of formaldehyde-induced DNA mono-adducts, support-
ing N2-HOMe-dG as a major biomarker of formaldehyde
exposure.
Method Validation and Artifact Determination
Details for method validation and artifact determination can
be found in Supplementary Results and Supplementary
Discussion. Briefly, the limit of detection values of [13C10
15N5]-
N2-Me-dG in DNA matrix on the Thermo TSQ Quantum
and the AB SCIEX Triple Quad 6500 [defined as signal to
noise (S/N)> 3] were 10 and 0.5 aMol, respectively. The
sodium phosphate buffer, as opposed to TrisHCl buffer or
PIPES buffer, did not produce significant matrix effects during
sample reduction and digestion, such as N2-Me-dG signal
suppression or enhancement. Moreover, minimal artifacts
were found to be generated from lipid oxidation in the pres-
ence of TrisHCl buffer in the NucleoBond DNA isolation kit
(Macherey-Nagel, Bethlehem, Pennsylvania), or from our
routine DNA isolation method. We demonstrated that less
than 1.1% artifact was associated with measurements of
endogenous formaldehyde DNA adducts.
Formation of N2-Hydroxymethyl-dG DNA Adducts In Vivo from
Endogenous and Exogenous Sources (28-Day Rat Inhalation
Exposure Study)
Following completion of exposures, tissue samples were col-
lected, immediately frozen, and stored at 80C until DNA isola-
tion, reduction, digestion, HPLC fractionation, and DNA adduct
quantitation by nano-LC-MS-MS. Figure 2A top panel shows the
chromatogram of N2-Me-dG in the nasal DNA from a rat
exposed to [13CD2]-formaldehyde for 7 days. The peak corre-
sponding to the specific transition of m/z 282.2 to m/z 166.1 rep-
resents the endogenous N2-Me-dG, which is the reduced form
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of N2-HOMe-dG derived from endogenous formaldehyde. The
bottom panel represents the internal standard, [13C10
15N5]-N
2-
Me-dG, in the transition of m/z 297.2 to m/z 176.1. The peak in
the middle panel corresponding to the transition of m/z 285.2 to
m/z 169.1 represents the exogenous [13CD2]-N
2-Me-dG, which is
the reduced form of [13CD2]-N
2-HOMe-dG derived from exoge-
nous [13CD2]-formaldehyde. Similarly, both endogenous and
exogenous DNA adducts can be clearly identified and quantified
in nasal epithelial DNA after 28 days of exposure, as shown in
Figure 2B and C. Compared with Figure 2A, the amount of exog-
enous [13CD2]-N
2-Me-dG in nasal DNA increased with extended
exposure time, indicating that DNA adducts in the form of N2-
HOMe-dG accumulated during the 28-day exposure period
in vivo. In control rats, equivalent amounts of endogenous
adducts and no exogenous adducts were observed (Fig. 2D
and E).
In all other tissues, only endogenous formaldehyde-induced
N2-HOMe-dG could be observed except for 1 bone marrow sam-
ple (Table 1) from a 28-day exposure rat. No signals correspond-
ing to the transition of m/z 285.2 to m/z 169.1 of exogenous
adducts were present following 28 days of labeled formaldehyde
exposure or in control rats. Furthermore, 2 additional transi-
tions monitoring the precursor masses of m/z 284.2 and 283.2
did not detect any exogenous DNA adducts arising from possi-
ble H-D exchange. Thus, with the exception of the 1 bone mar-
row sample mentioned earlier, there were no detectable
amounts of [13CD2]-N
2-HOMe-dG in sites remote to the portal of
entry after 28 days of exposure.
The amounts of endogenous N2-Me-dG and exogenous
[13CD2]-N
2-Me-dG in nasal respiratory epithelium, bone marrow,
and white blood cells were determined from replicate samples
(n¼ 4–12/time point) and are shown in Table 1. Amounts of
endogenous and exogenous DNA adducts in thymus, TBLN,
mediastinal lymph nodes, trachea, lung, spleen, kidney, liver,
and brain were determined in 28-day exposures and control
samples and are shown in Table 2.
Steady-State and Half-Life Modeling of Exogenous N2-
Hydroxymethyl-dG DNA Adducts In Vivo (28-Day Inhalation
Exposure Study)
As exogenous DNA adducts only existed in nasal respiratory
epithelium, the steady state and t1/2 estimations were based on
the amounts of [13CD2]-N
2-HOMe-dG that had accumulated at
various time points over the course of the 28-day exposure and
7-day postexposure periods (data from a single 6 h exposure to
2 ppm were included from a previous study) (Lu et al., 2011). As
FIG. 1. Hydrolytic degradation pathway and kinetics of DNA-protein crosslinks (DPCs). A, Degradation pathway; B–D, In vitro time dependence of the breakdown of
DPCs, the formation and degradation of N2-HOMe-dG, and the formation of dG. Inserted graph in B shows the time course reaction of dG-Me-Cys from 0 to 15 min. The
in vitro degradation study of crosslinks was performed at 37C in sodium phosphate buffer (20 mM, pH 7.2). Data represent mean 6 SD (n¼3).
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shown in Figure 3, the exogenous DNA adducts, [13CD2]-N
2-
HOMe-dG, approached a steady-state concentration during the
28-day exposure phase. After the last exposure, there was a
rapid initial loss of nearly 20% of the DNA adducts during the
6 h immediately following the last exposure. This rapid initial
loss was then followed by a much slower decrease in adducts
(Fig. 3). The t1/2 for the formation and repair/loss of [
13CD2]-N
2-
HOMe-dG adducts in nasal respiratory epithelium was esti-
mated to be 7.1 days, 90% confidence interval (CI)¼ [6.0, 8.7]
days using all of the data.
Formation of N2-Hydroxymethyl-dG DNA Adducts In Vivo
from Endogenous and Exogenous Sources (Monkey Inhalation
Exposure Study)
As shown in Table 3, combining our first monkey
[Nonhuman primate 1 (NHP1)] (Moeller et al., 2011) and sec-
ond monkey (NHP2) studies, both endogenous and exogenous
N2-HOMe-dG adducts were found in all regions of nasal pas-
sages studied. Moreover, the amounts of exogenous adducts
in different sections of the exposed monkey nasal epithelium
were 5- to 11-fold lower than endogenous adducts in the
FIG. 2. Typical nano-LC-MS-MS SRM chromatograms of endogenous and exogenous N2-Me-dG adducts in rat nasal respiratory epithelium. A, Seven-day exposed tissue
analyzed on Thermo TSQ Quantum; B, Twenty-eight-day exposed tissue analyzed on Thermo TSQ Quantum; C, Twenty-eight-day exposed tissue analyzed on AB
SCIEX Triple Quad 6500; D, Control rat tissue analyzed on Thermo TSQ Quantum; E, Control rat tissue analyzed on AB SCIEX Triple Quad 6500. Abbreviations: RT, reten-
tion time; MA, manual quantitated peak area; NL, normalized spectrum to largest peak in particular chromatogram; XIC, extracted-ion-chromatogram; NRE, nasal epi-
thelium; MRM, multiple reaction monitoring.
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corresponding sections in both exposed and air control mon-
key samples. In monkey bone marrow, white blood cells, and
trachea, only endogenous adducts were found; however,
the amount of endogenous N2-HOMe-dG adducts present
in direct scraped bone marrow was at least 2 times higher
than in collection using saline extrusion, indicating distinct
differences between these 2 bone marrow collection
procedures.
DISCUSSION
The formation of formaldehyde-induced DPCs has long been
thought to be a major form of DNA damage (Magana-
Schwencke and Ekert, 1978). Due to its significant biological
consequences, there have been investigations on formalde-
hyde-induced DPCs in animals and humans. Increased DPCs
were found in nasal samples of rats exposed to formaldehyde
at concentrations 2 ppm (Casanova et al., 1984). Similarly,
DPCs were formed in the respiratory tract of rhesus monkeys
exposed to formaldehyde at concentrations as low as 0.7 ppm
(Casanova et al., 1991). In those studies, no DPCs were
detected in the tissues distant to the contact site in rats and
monkeys exposed to formaldehyde at concentrations higher
than 6 ppm, such as lung and bone marrow. In contrast,
some studies have reported an apparent increase in DPCs in
circulating lymphocytes of humans exposed to ambient con-
centrations in the workplace (Shaham et al., 1996, 2003).
Increased DPCs were also found in several remote tissues,
such as bone marrow, liver, kidney, and testes of mice
exposed to inhaled formaldehyde (Ye et al., 2013).
The debate on the formation of formaldehyde-induced DPC
in the animal tissues distant to initial contact may be due to the
use of nonspecific DPC assays, such as potassium-SDS precipi-
tation and chloroform/iso-amyl alcohol/phenol extraction. The
methods lack specificity for the chemical composition of DPCs
(Stingele et al., 2014; Zhitkovich and Costa, 1992; Shaham et al.,
1996, 2003). Moreover, they cannot differentiate between exoge-
nous and endogenous formaldehyde-induced DPCs. Other stud-
ies have shown a rapid decline of the formaldehyde-induced
DPCs in cell cultures, and no accumulation of DPCs was
observed in rats after repeated exposure (Casanova et al., 1994;
Grafstrom et al., 1984; Shoulkamy et al., 2012). Further evidence
indicates that the major portions of formaldehyde-induced
DPCs are lost from lymphocytes through spontaneous
TABLE 1. Formation of N2-HOMe-dG Mono-Adducts (mean 6 SD) in Rat Nasal Epithelium, Bone Marrow, and White Blood Cells Exposed to
2 ppm Labeled Formaldehyde for 28 Days
Exposure Period Rat Nasal Epithelium Rat Bone Marrow Rat White Blood Cells
N2-HOMe-dG (adducts/107 dG) N2-HOMe-dG (adducts/107 dG) N2-HOMe-dG (adducts/107 dG)
Endogenousa Exogenous n Endogenousa Exogenous n Endogenousa Exogenous n
7 days 2.51 6 0.63 0.35 6 0.17 5 3.37 6 1.56 n.d. 6 2.62 6 1.12 n.d. 4
14 days 3.09 6 0.98 0.84 6 0.17 5 2.72 6 1.36 n.d. 6 2.26 6 0.46 n.d. 4
21 days 3.34 6 1.06 0.95 6 0.11 5 2.44 6 0.96 n.d. 6 2.40 6 0.47 n.d. 4
28 days 2.82 6 0.76 1.05 6 0.16 6 3.43 6 2.20 0.34 b 12 2.49 6 0.50 n.d. 4
28 daysþ 6 h postexpo 2.80 6 0.58 0.83 6 0.33 9 2.41 6 1.14 n.d. 6 2.97 6 0.58 n.d. 4
28 daysþ 24 h postexpo 2.98 6 0.70 0.80 6 0.46 9 4.67 6 1.84 n.d. 5 2.57 6 0.58 n.d. 4
28 daysþ 72 h postexpo 2.99 6 0.63 0.63 6 0.12 9 5.55 6 0.76 n.d. 6 1.75 6 0.26 n.d. 4
28 daysþ 168 h postexpo 2.78 6 0.48 0.67 6 0.20 10 2.78 6 1.94 n.d. 4 2.61 6 1.22 n.d. 4
Air control 2.84 6 0.54 n.d. 8 3.58 6 0.99 n.d. 6 2.76 6 0.66 n.d. 6
aNo statistically significant difference was found using the 2-sided Dunnett’s test (multiple comparisons with a control) (Dunnett, 1964).
bThe amount of exogenous N2-HOMe-dG adducts that was found in only 1 bone marrow sample analyzed by AB SCIEX Triple Quad 6500.
n.d., not detected.
TABLE 2. Formation of N2-HOMe-dG Mono-Adducts (Mean 6 SD) in Rat Thymus, Tracheal Bronchial Lymph Nodes, Mediastinal Lymph Nodes,
Trachea, Lung, Spleen, Kidney, Liver, and Brain Exposed to 2 ppm Labeled Formaldehyde for 28 Days
Rat tissues Exposure Period N2-HOMe-dG (adducts/107 dG) Exposure Period N2-HOMe-dG (adducts/107 dG)
Endogenous Exogenous n Endogenous Exogenous n
Thymusa 28 days 0.63 6 0.06 n.d. 4 Air control 0.78 6 0.04 n.d. 4
TBLN 3.01 6 0.71 n.d. 4 3.46 6 1.24 n.d. 4
Lymph nodes 2.80 6 1.38 n.d. 4 2.99 6 0.85 n.d. 4
Trachea 2.63 6 0.92 n.d. 4 3.18 6 0.72 n.d. 4
Lung 2.13 6 0.26 n.d. 4 2.29 6 0.24 n.d. 4
Spleen 1.83 6 0.25 n.d. 4 2.18 6 0.19 n.d. 4
Kidney 1.99 6 0.09 n.d. 4 2.17 6 0.60 n.d. 4
Liver 1.80 6 0.02 n.d. 4 1.97 6 0.38 n.d. 4
Brain 2.35 6 1.00 n.d. 4 2.13 6 0.17 n.d. 4
aStatistically significant difference was found using the 2-sided unpaired Student’s t-tests.
TBLN, tracheal bronchial lymph nodes.
n.d., not detected.
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FIG. 3. Estimated time for exogenous [13CD2]-N
2-HOMe-dG adducts to reach the steady-state concentration and t1/2 of exogenous [
13CD2]-N
2-HOMe-dG adducts following
a 2 ppm (6 h/day) exposure for 28 days (observed [mean 6 SD] and predicted [solid line]) in rat nasal epithelium. Data from a single 6 h exposure to 2 ppm (cubic dot)
were included from a previous study (Lu et al., 2011), n¼ 5. The numbers of other data points (n) are indicated in Table 1. Triangle dots represent real data with error
bars, and the zigzag line represents predicted trends of the accumulation and decay during the exposure and postexposure period.
TABLE 3. Formation of N2-HOMe-dG Mono-Adducts (Mean 6 SD) in Monkey Nasal Epithelium, Bone Marrow, White Blood Cells, and Trachea
Exposed to 2 and 6 ppm Labeled Formaldehyde for 2 Days




NHP1a Nasal maxillo-turbinate 1.9 ppm 2.50 6 0.40 0.26 6 0.04 3
6.1 ppm 2.05 6 0.54 0.41 6 0.05 3
Scraped bone marrow 1.9 ppm 17.50 6 2.60 n.d. 3
6.1 ppm 12.40 6 3.60 n.d. 3
NHP2 Nasal dorsal mucosa 6 ppm 3.62 6 1.28 0.40 6 0.07 4
Air control 3.81 6 1.19 n.d. 4
Nasal nasopharynx 6 ppm 3.62 6 1.34 0.33 6 0.10 4
Air control 3.48 6 0.53 n.d. 4
Nasal septum 6 ppm 3.56 6 0.69 0.39 6 0.15 4
Air control 3.75 6 0.32 n.d. 4
Nasal anterior maxillary 6 ppm 3.80 6 0.91 0.34 6 0.12 4
Air control 4.21 6 0.53 n.d. 4
Nasal posterior maxillary 6 ppm 3.46 6 1.05 0.36 6 0.16 4
Air control 3.95 6 0.74 n.d. 4
Scraped bone marrow 6 ppm 11.00 6 2.01 n.d. 10
Air control 10.18 6 1.35 n.d. 10
Saline extrusion bone marrow 6 ppm 4.41 6 1.00 n.d. 10
Air control 5.65 6 2.12 n.d. 4
White blood cells 6 ppm 3.79 6 1.19 n.d. 4
Air control 3.64 6 1.09 n.d. 4
Trachea carina 6 ppm 2.33 6 1.12 n.d. 4
Air control 2.69 6 0.95 n.d. 4
Trachea proximal 6 ppm 2.50 6 1.10 n.d. 4
Air control 2.35 6 1.05 n.d. 4
aNHP, Nonhuman primate.
n.d., not detected.
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hydrolysis, rather than being actively repaired (Quievryn and
Zhitkovich, 2000). This raises the important question of whether
another type of DNA damage is generated through DPC
hydrolysis.
Previous in vitro studies demonstrated DPCs were induced by
formaldehyde with formation of N-CH2-N and N-CH2-S linkages
between DNA and protein (Heck et al., 1990). To study the chem-
ical identity of formaldehyde-induced DPCs, we investigated
the in vitro crosslinking reaction between nucleosides, nucleoti-
des, and amino acids and peptides in the presence of formalde-
hyde (Lu et al., 2010b). Our results demonstrate that the most
abundant crosslink was formed with N-CH2-N linkage between
dG and lysine. Unfortunately, the lability of N-CH2-N linkage in
crosslinks has prevented the isolation of these compounds and
characterization of their chemical structures by spectroscopic
methods. On the other hand, the second most abundant cross-
link was formed with N-CH2-S linkage between dG and cysteine,
and was stable enough to be characterized. It should be also
noted that formaldehyde exposure is associated with oxidative
stress in animals and humans, resulting in the production of
reactive oxygen species that can cause DNA adducts, such as
malondialdehyde-deoxyguanosine (Bono et al., 2010). Although
there is lack of evidence on the formation of indirect DPCs
in vivo arising from oxidative stress after formaldehyde expo-
sure, we cannot rule out the possibility that reactive oxygen
species can interact with DNA and protein to form indirect DPCs
based on their high reactivity. However, it has not been possible
to know the chemical identity of formaldehyde-induced DPCs
formed in vivo due to the lack of chemical specific and accurate
measurement. In this study, dG-Me-Cys containing N-CH2-S
linkage was chosen for the degradation experiments based on
its relatively high stability and abundance (Lu et al., 2010b).
This study also included degradation of other crosslinks, dG-
Me-GSH, and dG-Me-AGT, both containing N-CH2-S linkage.
Formaldehyde has been reported to induce dG-Me-GSH follow-
ing incubation of formaldehyde with reduced GSH and calf thy-
mus DNA (Lu et al., 2009). This finding raises the possibility that
dG-Me-GSH can form endogenously, because both formalde-
hyde and GSH are present in reasonably high concentrations
innately within cells (Swenberg et al., 1980). The results of our
investigations on the hydrolytic degradation of formaldehyde-
induced DPCs demonstrate clearly that DPC hydrolysis involves
breakdown to the DNA mono-adduct, N2-HOMe-dG, followed by
further degradation to dG. These results suggest that DPCs are
likely to be an important source of formaldehyde-induced DNA
mono-adducts and such mono-adducts represent a biomarker
of both direct attack of DNA and a breakdown product of DPCs.
With the support of powerful analytical instruments and
improved methodology, endogenous formaldehyde-induced N2-
HOMe-dG adducts were observed in all rat and monkey
tissues analyzed. However, exogenous formaldehyde-induced
[13CD2]-N
2-HOMe-dG adducts were only detected in the nasal
respiratory epithelial DNA (with the exception of the 1/95 rat
bone marrow samples) (Fig. 2; Tables 1–3). These results were in
accord with our previous studies (Lu et al., 2010a, 2011; Moeller
et al., 2011), providing compelling evidence that inhaled formal-
dehyde does not reach tissues distant to the site of initial con-
tact. Thus, the plausibility of speculative hypotheses that
inhaled formaldehyde causes leukemia via direct DNA damage
must be seriously questioned.
The numbers of exogenous N2-HOMe-dG adducts found in
rat and monkey nasal epithelium were all substantially smaller
than the corresponding numbers of endogenous adducts
(Tables 1 and 3). Surprisingly, 1 bone marrow sample from the
95 exposed rats contained 0.34 exogenous N2-HOMe-dG
adducts/107 dG (¼0.19 fMol N2-Me-dG on column) (Tables 1 and
4). The question remains why exogenous N2-HOMe-dG adducts
were not found in the other 94 exposed rats. Considering all the
bone marrow samples we have previously analyzed (Lu et al.,
2010a, 2011; Moeller et al., 2011), this was the only instance out
of 121 rats and primates where exogenous adducts were
detected in bone marrow samples. Moreover, the amounts of
endogenous adducts in air control rat bone marrow match very
nicely with the corresponding amounts measured in the
28-day-exposed rat bone marrow.
A statistically significant difference was found between the
amounts of endogenous adducts present in the thymus of
exposed and air control rats (Table 2). However, this difference
(0.15 adducts/107 dG) is the smallest of any of the differences
that were obtained in the various tissues examined, with none
of the other differences being either biologically or statistically
significant. We therefore consider the statistical significance of
the small thymus difference to simply be a chance finding that
arose as a result of the surprisingly tight SD estimates for the
thymus data.
Similar findings have been demonstrated for N6-formylly-
sine, a chemical homolog of biologically important N6-acetylly-
sine that has recently emerged as a widespread modification of
proteins. Studies conducted at Massachusetts Institute of
Technology that utilized the same animal tissues have inde-
pendently demonstrated that [13CD2]-N
6-formyllysine was only
present in the rat nasal epithelium. Likewise, tissues distant to
the site of contact only had endogenous N6-formyllysine.
Furthermore, accumulation of [13CD2]-N
6-formyllysine adducts
was only detected in the nasal epithelium (Edrissi et al., 2014).
Similar tissue distributions were also reported in a rat dosime-
try study (Edrissi et al., 2013).
The 28-day rat study demonstrates both accumulation and
attainment of quasi-steady-state concentrations of exogenous
formaldehyde-induced [13CD2]-N
2-HOMe-dG adducts in nasal
epithelium over a 28-day exposure period (Fig. 3). Due to the
instability of N2-HOMe-dG, its t1/2 was modeled pharmacokineti-
cally and estimated with the model parameters. Similar to the
previous 10 ppm exposure study (Swenberg et al., 2013), there
was a rapid initial loss of nearly 20% of the adducts in the first
6 h postexposure. This rapid initial loss was followed by a much
slower decrease in adducts with a t1/2 estimated to be 7.1 days
TABLE 4. Formation of Endogenous N2-HOMe-dG Mono-Adducts
(Mean 6 SD) in Various Tissues in All Rat [13CD2]-Formaldehyde
Exposure Studies.
Rat Tissues Endogenous N2-HOMe-dG
(adducts/107 dG)
n
Nasal epithelium 3.26 6 0.97 147
Bone marrowa 3.41 6 0.99 95
White blood cells 1.90 6 0.50 71
Lung 2.37 6 0.25 18
Liver 2.48 6 0.35 18
Spleen 2.20 6 0.35 18
Thymus 1.47 6 0.11 18
TBLN 3.24 6 0.98 8
Lymph nodes 2.90 6 1.12 8
Trachea 2.91 6 0.82 8
Kidney 2.08 6 0.35 8
Brain 2.24 6 0.59 8
aExogenous N2-HOMe-dG was only detectable in 1/95 rat bone marrow sample.
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(Fig. 3), which is believed to reflect DNA repair and/or spontane-
ous hydrolysis. In the 10 ppm exposure study, the rapid loss
during the first 6-h postexposure is thought to be the result of
cell death, but not DNA repair. In the current 28-day study,
2 ppm inhalation exposures to formaldehyde should have not
resulted in prominent decreases in DNA mono-adducts due
to cytotoxicity. Thus, the mechanism responsible for
the apparent rapid initial loss of exogenous N2-HOMe-dG
remains unknown.
In the first monkey study (Moeller et al., 2011), the amount of
endogenous N2-HOMe-dG was found to be extremely high in
scraped bone marrow (Table 3). Thus, 2 different collection
methods were used in the second monkey study, traditional sal-
ine extrusion, and direct scraping. The amount of endogenous
N2-HOMe-dG adduct present in direct scraped bone marrow was
found to be at least 2-fold higher than in saline extrusion
(Table 3). Because the saline extruded bone marrow is likely to
contain predominantly blood, the number of DNA adducts in
these samples would be diluted by the relatively low amount of
DNA adducts present in blood. In contrast, the large number of
DNA adducts found in direct bone marrow scraping reflects the
true value of endogenous DNA damage. These data support our
hypothesis that endogenous formaldehyde induced DNA dam-
age in bone marrow could result in “spontaneous” mutations
and thus may represent an important source of leukemia and
bone marrow failure (BMF).
Of immediate interest to both EPA and our lab, we also
investigated whether or not inhaled formaldehyde could cause
an increase in the amounts of endogenous formaldehyde-
induced DNA adducts. As background information, formalde-
hyde clearance is predominantly mediated by a saturable path-
way, glutathione conjugation. Thus, additional exposures of
exogenous formaldehyde might interfere with the clearance of
endogenous formaldehyde. As shown in Tables 1–3, the average
endogenous amount of N2-HOMe-dG in each exposed tissue
was not significantly different from the corresponding values in
control tissues. We conclude, therefore, that neither a 28-day
2 ppm nor a 2-day 6 ppm [13CD2]-formaldehyde exposure of rats
or monkeys resulted in any significant change in the number of
endogenous N2-HOMe-dG, indicating that inhaled exogenous
formaldehyde at these concentrations does not induce detect-
able changes in the amounts of endogenous formaldehyde-
induced DNA adducts. By pooling data from all rat exposure
studies we have conducted (Table 4, Supplementary Table SI-4),
there was no significant difference (P¼ .1 and .2) in the amount
of endogenous adducts between exposed groups and non-
exposed groups. It should be pointed out, however, that inhala-
tion exposure to approximately 15 ppm formaldehyde for 28
days or longer has not been tested. Such high exposures might
conceivably induce increases in endogenous DNA adducts due
to depletion of glutathione.
With high amounts of endogenous DNA adducts always
present, we expect that the endogenous DNA damage results in
“spontaneous” mutations and represents an important source
and initiator of cancer, leukemia, and other diseases (Ames,
1989; Swenberg et al., 2008), especially when compared with low
environmental concentrations. Many reactive aldehydes are
endogenously produced within humans (Nakamura et al., 2014;
Voulgaridou et al., 2011). Most of them cause DNA damage, and
some of them accumulate due to inherited genetic mutations
and detoxification deficiencies. ALDH2 is mutated in
approximately 1 billion people, most frequently observed in
Southeast Asians, and is commonly known as the Asian flush-
ing syndrome. FA is a genetic disease with an incidence of 1 per
350 000 births, with a higher frequency in Ashkenazi Jews and
Afrikaners in South Africa. It is the result of a genetic defect in a
cluster of proteins responsible for DNA repair (Hira et al., 2013)
have recently found that ALDH2 deficiency dramatically accel-
erates BMF in Japanese FA patients. Most strikingly, those
patients entirely deficient for ALDH2 developed BMF within the
first 7 months of life (Hira et al., 2013). Patel’s laboratory has
demonstrated that blocking ADH5 (formaldehyde dehydrogen-
ase) or ALDH2 triggered DNA damage and was indeed genotoxic
to hematopoietic stem cells, causing FA mice to spontaneously
develop acute leukemia and profound BMF (Garaycoechea et al.,
2012; Garaycoechea and Patel, 2014; Langevin et al., 2011). These
reports confirm unequivocally that endogenous aldehydes are
sufficient to cause DNA damage and induce leukemia and BMF
in both humans and mice deficient in aldehyde detoxification
and DNA repair.
Risk assessment practices have progressed from minimal
incorporation of mechanistic data and reliance on linearly
extrapolated models for low-dose risk assessment, to greater
emphasis on Mode of Action and the incorporation of scientific
data into the risk assessment process. Yet, some scientists and
risk assessors continue to support the use of linear low-dose
risk assessment over the incorporation of scientific data into
the decision-making process (National Research Council, 2009).
There are important questions that need to be addressed. For
example, which exposure, exogenous or endogenous, is driving
mutagenesis or carcinogenesis at low exposures? What is the
safe exposure level of formaldehyde when substantial amounts
of endogenous formaldehyde are always present in vivo? Results
from the present study, as well as previous studies (Lu et al.,
2010a, 2011; Moeller et al., 2011), provide critical data that
improve our ability to develop science-based cancer risk assess-
ments utilizing known biology and toxicology related to formal-
dehyde and cancer, rather than relying on default approaches
like linear low-dose extrapolation. The NRC Review of the EPA’s
Draft IRIS Assessment of Formaldehyde in 2011 strongly sug-
gested that such data should be incorporated explicitly into a
revised risk assessment.
CONCLUSIONS
In summary, N2-HOMe-dG was shown to be the only dominant
product of several formaldehyde-induced DPCs investigated.
These DPCs are likely to be an important source of formalde-
hyde-induced DNA mono-adducts that represent a biomarker of
both direct attack of DNA and a breakdown product of DPCs.
Possible origins of interfering artifacts were identified, mini-
mized, or eliminated throughout the analyses. Plus, with the
application of highly sensitive instruments and accurate assays,
inhaled formaldehyde was found to reach nasal respiratory epi-
thelium, but not other tissues distant to the site of initial con-
tact in the 28-day 2 ppm exposure rat study as well as in the
2-day 6 ppm exposure monkey study. In contrast, endogenous
N2-HOMe-dG adducts were readily detected in all tissues exam-
ined with remarkably higher amounts present. Therefore, the
plausibility of speculative hypotheses that inhaled formalde-
hyde causes leukemia must be seriously questioned. Moreover,
the amounts of exogenous formaldehyde-induced N2-HOMe-dG
adducts were 3- to 8-fold and 5- to 11-fold lower than the aver-
age amounts of endogenous formaldehyde-induced N2-HOMe-
dG adducts in rat and monkey nasal respiratory epithelium,
respectively. Thus, our improved understanding that ever-
present endogenous formaldehyde leads to the formation of
severe DNA lesions (both DPCs and DNA mono-adducts)
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warrants reflection. Historically, the risk to humans from
inhaled formaldehyde may have been over-stated and the role
of endogenous formaldehyde in the development and progres-
sion of bone marrow toxicity and leukemia may have been
under-appreciated. To this end, we have developed a conserva-
tive approach to estimating risks to the general population from
endogenous and low concentrations of exogenous formalde-
hyde (Starr and Swenberg, 2013), and have highlighted the
importance of considering endogenous sources of DPCs and
DNA mono-adducts during the risk assessment process.
SUPPLEMENTARY DATA
Supplementary data are available online at http://toxsci.
oxfordjournals.org/.
FUNDING
National Institutes of Health (P42 ES005948, P30 ES010126 to
J.A.S.); Texas Commission for Environmental Quality (582-
12-21861 to J.A.S); The Research Foundation for Health and
Environmental Effects (RFHEE) and Formacare provided the
support to Lovelace Respiratory Research Institute for the
animal exposures. RFHEE also covered the cost of mass
spectrometry analyses at UNC. TCEQ provided partial sup-
port for supplies and laboratory personnel. None of the
funding organizations see any draft or submitted manu-
scripts from the Swenberg Laboratory until the article has
been accepted for publication and is available online.
ACKNOWLEDGMENTS
The authors acknowledge the support of Valeriy Afonin for
his assistance with the isolation of DNA from tissues,
Leonard Collins for his assistance with HPLC purification
and nano-UPLC-MS-MS, and Dr Zhengfa Zhang and
Dr Avran Gold for their assistance with the synthesis of
standards.
REFERENCES
Ames, B. N. (1989). Endogenous DNA damage as related to cancer
and aging. Mutat. Res. 214, 41–46.
Beane Freeman, L. E. B., Blair, A., Lubin, J. H., Stewart, P. A.,
Hayes, R. B., Hoover, R. N., and Hauptmann, M. (2009).
Mortality from lymphohematopoietic malignancies among
workers in formaldehyde industries: The National Cancer
Institute Cohort. J. Natl. Cancer Inst. 101, 751–761.
Bono, R., Romanazzi, V., Munnia, A., Piro, S., Allione, A., Ricceri,
F., Guarrera, S., Pignata, C., Matullo, G., Wang, P., et al. (2010).
Malondialdehyde-deoxyguanosine adduct formation in
workers of pathology wards: The role of air formaldehyde ex-
posure. Chem. Res. Toxicol. 23, 1342–1348.
Casanova, M., Morgan, K. T., Gross, E. A., Moss, O. R., and
Heck, H. D. (1994). DNA-protein cross-links and cell repli-
cation at specific sites in the nose of F344 rats exposed
subchronically to formaldehyde. Fundam. Appl. Toxicol. 23,
525–536.
Casanova, M., Morgan, K. T., Steinhagen, W. H., Everitt, J. I.,
Popp, J. A., and Heck, H. D. (1991). Covalent binding of in-
haled formaldehyde to DNA in the respiratory tract of
rhesus monkeys: Pharmacokinetics, rat-to-monkey
interspecies scaling, and extrapolation to man. Fundam.
Appl. Toxicol. 17, 409–428.
Casanova, M., Starr, T. B., and Heck, H. D. (1984). Differentiation
between metabolic incorporation and covalent binding in
the labeling of macromolecules in the rat nasal mucosa and
bone marrow by inhaled [14C]- and [3H]-formaldehyde.
Toxicol. Appl. Pharmacol. 76, 26–44.
Casanova-Schmitz, M., and Heck, H. D. (1983). Effects of form-
aldehyde exposure on the extractability of DNA from pro-
teins in the rat nasal mucosa. Toxicol. Appl. Pharmacol. 70,
121–132.
Coggon, D., Ntani, G., Harris, E. C., and Palmer, K. T. (2014). Upper
airway cancer, myeloid leukemia, and other cancers in a co-
hort of British chemical workers exposed to formaldehyde.
Am. J. Epidemiol. 179, 1301–1311.
Committee to Review EPA’s Draft IRIS Assessment of
Formaldehyde & National Research Council. (2011). Review of
the Environmental Protection Agency’s Draft IRIS Assessment of
Formaldehyde. National Academies Press, Washington, D. C.
Dunnett, C. W. (1964). New tables for multiple comparisons with
a control. Biometrics 20, 482–491.
Edrissi, B., Taghizadeh, K., Moeller, B. C., Kracko, D., Doyle-Eisele,
M., Swenberg, J. A., and Dedon, P. C. (2013). Dosimetry of
N6-formyllysine adducts following [13C2H2]-formaldehyde
exposures in rats. Chem. Res. Toxicol. 26, 1421–1423.
Edrissi, B., Taghizadeh, K., Moeller, B. C., Yu, R., Kracko, D.,
Doyle-Eisele, M., Swenberg, J. A., and Dedon, P. C. (2014).
N6-Formyllysine as a biomarker of formaldehyde exposure:
Inhalation studies in rats reveal formation and accumulation
of N6-Formyllysine adducts in nasal epithelium.
The Toxicologist 138, 398.
Garaycoechea, J. I., Crossan, G. P., Langevin, F., Daly, M., Arends,
M. J., and Patel, K. J. (2012). Genotoxic consequences of en-
dogenous aldehydes on mouse haematopoietic stem cell
function. Nature 489, 571–575.
Garaycoechea, J. I., and Patel, K. J. (2014). Why does the bone
marrow fail in Fanconi anemia? Blood 123, 26–34.
Grafstrom, R. C., Fornace, A., and Harris, C. C. (1984). Repair of
DNA damage caused by formaldehyde in human cells. Cancer
Res. 44, 4323–4327.
Heck, H. D., Casanova, M., and Starr, T. B. (1990).
Formaldehyde toxicity-new understanding. Crit. Rev. Toxicol.
20, 397–426.
Hira, A., Yabe, H., Yoshida, K., Okuno, Y., Shiraishi, Y., Chiba, K.,
Tanaka, H., Miyano, S., Nakamura, J., Kojima, S., et al. (2013).
Variant ALDH2 is associated with accelerated progression of
bone marrow failure in Japanese Fanconi anemia patients.
Blood 122, 3206–3209.
International Agency for Research on Cancer. (2006).
Formaldehyde, 2-Butoxyethanol and 1-tert-Butoxypropan-2-
ol. In: IARC Monographs on the Evaluation of Carcinogenic Risks to
Humans, Vol. 88, 1–287.
International Agency for Research on Cancer. (2012).
Formaldehyde, A review of human carcinogens. Part F:
Chemical Agents and Related Occupations, Vol. 100, 401–435.
Langevin, F., Crossan, G. P., Rosado, I. V., Arends, M. J.,
and Patel, K. J. (2011). Fancd2 counteracts the toxic
effects of naturally produced aldehydes in mice. Nature
475, 53–58.
Lu, K., Collins, L. B., Ru, H., Bermudez, E., and Swenberg, J. A.
(2010a). Distribution of DNA adducts caused by inhaled form-
aldehyde is consistent with induction of nasal carcinoma but
not leukemia. Toxicol. Sci. 116, 441–451.
YU ET AL. | 181
Lu, K., Moeller, B. C., Doyle-Eisele, M., McDonald, J., and
Swenberg, J. A. (2011). Molecular dosimetry of N2-hydroxy-
methyl-dG DNA adducts in rats exposed to formaldehyde.
Chem. Res. Toxicol. 24, 159–161.
Lu, K., Ye, W., Gold, A., Ball, L. M., and Swenberg, J. A. (2009).
Formation of S-[1-(N2-deoxyguanosinyl) methyl]glutatione
between glutathione and DNA induced by formaldehyde.
J. Am. Chem. Soc. 131, 3414–3415.
Lu, K., Ye, W., Zhou, L., Collins, L. B., Chen, X., Gold, A., Ball, L. M.,
and Swenberg, J. A. (2010b). Structural characterization of
formaldehyde-induced cross-links between amino acids and
deoxynucleosides and their oligomers. J. Am. Chem. Soc. 132,
3388–3399.
Magana-Schwencke, N., and Ekert, B. (1978). Biochemical analy-
sis of damage induced in yeast by formaldehyde. II.
Induction of cross-links between DNA and protein. Mutat.
Res. 51, 11–19.
McGhee, J. D., and von Hippel, P. H. (1977). Formaldehyde as a
probe of DNA structure. r. Mechanism of the initial reaction
of formaldehyde with DNA. Biochemistry 16, 3276–3293.
Moeller, B. C., Lu, K., Doyle-Eisele, M., McDonald, J., Gigliotti, A.,
and Swenberg, J. A. (2011). Determination of N2-hydroxy-
methyl-dG adducts in nasal epithelium and bone marrow of
non-human primates following 13CD2-formaldehyde inhala-
tion exposure. Chem. Res. Toxicol. 24, 162–164.
Nakamura, J., Mutlu, E., Sharma, V., Collins, L. B., Bodnar, W., Yu,
R., Lai, Y., Moeller, B. C., Lu, K., and Swenberg, J. A. (2014). The
endogenous exposome. DNA Repair 19, 3–13.
National Research Council. (2009). Science and decisions:
Advancing risk assessment. National Academies Press,
Washington, D. C.
Quievryn, G., and Zhitkovich, A. (2000). Loss of DNA-protein
crosslinks from formaldehyde-exposed cells occurs through
spontaneous hydrolysis and an active repair process linked
to proteosome function. Carcinogenesis 21, 1573–1580.
Rosado, I. V., Langevin, F., Crossan, G. P., Takata, M., and Patel, K.
J. (2011). Formaldehyde catabolism is essential in cells defi-
cient for the Fanconi anemia DNA-repair pathway. Nat.
Struct. Mol. Biol. 18, 1432–1434.
Shaham, J., Bomstein, Y., Gurvich, R., Rashkovsky, M., and
Kaufman, Z. (2003). DNA-protein crosslinks and p53 protein
expression in relation to occupational exposure to formalde-
hyde. Occup. Environ. Med. 60, 403–409.
Shaham, J., Bomstein, Y., Meltzer, A., Kaufman, Z., Palma, E., and
Ribak, J. (1996). DNA-protein crosslinks, a biomarker of expo-
sure to formaldehyde–in vitro and in vivo studies.
Carcinogenesis 17, 121–125.
Shoulkamy, M. I., Nakano, T., Ohshima, M., Hirayama, R., Uzawa,
A., Furusawa, Y., and Ide, H. (2012). Detection of DNA-protein
crosslinks (DPCs) by novel direct fluorescence labeling meth-
ods: Distinct stabilities of aldehyde and radiation-induced
DPCs. Nucleic Acids Res. 40, e143.
Solomon, M. J., and Varshavsky, A. (1985). Formaldehyde-medi-
ated DNA-protein crosslinking: A probe for in vivo chromatin
structures. Proc. Natl. Acad. Sci. U.S.A. 82, 6470–6474.
Starr, T. B., and Swenberg, J. A. (2013). A novel bottum-up
approach to bounding low-dose human cancer risks
from chemical exposures. Regul. Toxicol. Pharmacol. 65,
311–315.
Stingele, J., Schwarz, M. S., Bloemeke, N., Wolf, P. G., and Jentsch,
S. (2014). A DNA-depedent protease involved in DNA-protein
crosslink repair. Cell 158, 327–338.
Swenberg, J. A., Fryar-Tita, E., Jeong, Y. C., Boysen, G., Starr, T. B.,
Walker, V. E., and Albertini, R. J. (2008). Biomarkers in toxicol-
ogy and risk assessment: Informing critical dose-response
relationships. Chem. Res. Toxicol. 21, 253–265.
Swenberg, J. A., Kerns, W. D., Mitchell, R. I., Gralla, E. J., and
Pavkov, K. L. (1980). Induction of squamous cell carcinomas
of the rat nasal cavity by inhalation exposure to formalde-
hyde vapor. Cancer Res. 40, 3398–3402.
Swenberg, J. A., Moeller, B. C., Lu, K., Rager, J. E., Fry, R. C., and
Starr, T. B. (2013). Formaldehyde carcinogenicity research: 30
years and counting for mode of action, epidemiology, and
cancer risk assessment. Toxicol. Pathol. 41, 181–189.
Voulgaridou, G. P., Anestopoulos, I., Franco, R., Panayiotidis, M.
I., and Pappa, A. (2011). DNA damage induced by endogenous
aldehydes: Current state of knowledge. Mutat. Res. 711,
13–27.
Ye, X., Ji, Z., Wei, C., McHale, C. M., Ding, S., Thomas, R., Yang, X.,
and Zhang, L. (2013). Inhaled formaldehyde induces DNA-
protein crosslinks and oxidative stress in bone marrow and
other distant organs of exposed mice. Environ. Mol. Mutagen.
54, 705–718.
Zhitkovich, A., and Costa, M. (1992). A simple, sensitive assay to
detect DNA-protein crosslinks in intact cells and in vivo.
Carcinogenesis 13, 1485–1489.
182 | TOXICOLOGICAL SCIENCES, 2015, Vol. 146, No. 1
